EGM
VKTX icon

Engineers Gate Manager’s Viking Therapeutics VKTX Stock Holding History

Engineers Gate Manager’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.82M Buy
+46,735
New +$1.51M 0.02% 745
2025
Q4 		– Sell
-61,467
Closed -$1.62M – 2583
2025
Q3 		$1.62M Buy
61,467
+48,619
+378% +$1.45M 0.02% 888
2025
Q2 		$340K Sell
12,848
-66,915
-84% -$1.76M ﹤0.01% 1658
2025
Q1 		$1.93M Buy
79,763
+52,515
+193% +$1.66M 0.03% 707
2024
Q4 		$1.1M Sell
27,248
-160
-0.6% -$9.12K 0.02% 949
2024
Q3 		$1.74M Buy
27,408
+17,675
+182% +$1.04M 0.03% 712
2024
Q2 		$516K Buy
+9,733
New +$638K 0.01% 1205
2024
Q1 		– Sell
-13,853
Closed -$258K – 2332
2023
Q4 		$258K Sell
13,853
-41,740
-75% -$546K 0.01% 1534
2023
Q3 		$615K Buy
+55,593
New +$795K 0.02% 958
2023
Q2 		– Sell
-14,034
Closed -$234K – 2059
2023
Q1 		$234K Buy
+14,034
New +$145K 0.01% 1365
2022
Q2 		– Sell
-12,370
Closed -$37K – 2290
2022
Q1 		$37K Buy
+12,370
New +$44.4K ﹤0.01% 1769
2020
Q2 		– Sell
-10,500
Closed -$49K – 1992
2020
Q1 		$49K Buy
+10,500
New +$64.5K ﹤0.01% 1482

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Engineers Gate Manager's VKTX Position: Q2 2026 in Review

Engineers Gate Manager opened a new position in Viking Therapeutics (VKTX) in Q2 2026: 46,735 shares worth $1.82M. The stake represents 0.02% of the portfolio and ranks #745 among its holdings. This is a return to the name: Engineers Gate Manager previously reported a position in VKTX as recently as Q3 2025.

Engineers Gate Manager first reported a position in VKTX in Q1 2020 and has held it in 12 quarters since. The position peaked at $1.93M in Q1 2025. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Engineers Gate Manager held 46,735 shares of Viking Therapeutics worth $1.82M as of Q2 2026.
  • Viking Therapeutics was a new Engineers Gate Manager position in Q2 2026.
  • Viking Therapeutics made up 0.02% of Engineers Gate Manager's portfolio in Q2 2026, its #745 holding.
  • Engineers Gate Manager first reported a position in Viking Therapeutics in Q1 2020 and has held it in 12 quarters since.
  • Engineers Gate Manager's Viking Therapeutics position peaked at $1.93M in Q1 2025.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.